𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Phase II trial of temozolomide in low-grade non-Hodgkin's lymphoma

✍ Scribed by Woll, PJ; Crowther, D; Johnson, PWM; Soukop, M; Harper, PG; Harris, M; Brampton, MH; Newlands, ES

Book ID
109837143
Publisher
Nature Publishing Group
Year
1995
Tongue
English
Weight
359 KB
Volume
72
Category
Article
ISSN
0007-0920

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Phase II trial of bisantrene in patients
Phase II trial of bisantrene in patients with intermediate and high grade diffuse non-Hodgkin's lymphomas
✍ Thomas P. Miller; Stephen E. Jones; David S. Alberts; Cindy Mackel πŸ“‚ Article πŸ“… 1984 πŸ› Springer US 🌐 English βš– 239 KB

Sixteen heavily pretreated patients with advanced intermediate and high-grade diffuse non-Hodgkin's lymphoma (NHL) were treated with 260 mg/M2 of bisantrene every three weeks. Thirty infusions of bisantrene were given without evidence of objective response. Pain in the infused arm, with or without s

Treatment of low-grade non-Hodgkin's lym
Treatment of low-grade non-Hodgkin's lymphomas: Assessment of doxorubicin in a controlled trial
✍ Dr. E. Lepage; C. Sebban; C. Gisselbrecht; B. Coiffier; J. L. Harousseau; P. A. πŸ“‚ Article πŸ“… 1990 πŸ› John Wiley and Sons 🌐 English βš– 501 KB

From 1981 to 1984 a randomized clinical trial was conducted to evaluate the role of doxorubicin in low grade malignancy non-Hodgkin's lymphoma (NHL). One hundred and thirteen patients were treated by an induction regimen including cyclophosphamide 400 mg/m2 day I and 8, vincristine 1.4 mg/m2 day 1 a

A phase II trial of promace-cytabom in p
A phase II trial of promace-cytabom in previously untreated non-hodgkin's lymphoma of intermediate- or high-grade histology
✍ G. Rossi; M. R. Mariano; G. Arcangeli; V. Bonfanti; M. A. Capucci; P. Ferremi; P πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 560 KB

the aggressive combination chemotherapy programme ProMACE-CytaBOM was used at a community-based hospital as primary treatment for non-Hodgkin's lymphoma (NHL) of intermediate or high-grade histology in Ann-Arbor stages IB-IV. The 53 patients entering the study represented 90 per cent of all consecut